BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32154163)

  • 1. L-Ascorbic Acid and α-Tocopherol Synergistically Triggers Apoptosis Inducing Antileukemic Effects of Arsenic Trioxide
    Vineetha RC; Hariharan S; Jaleel A; Chandran M; Nair RH
    Front Oncol; 2020; 10():65. PubMed ID: 32154163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors.
    Vineetha RC; Binu P; Arathi P; Nair RH
    Toxicol Mech Methods; 2018 Jun; 28(5):353-360. PubMed ID: 29297235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Ascorbic Acid and α-Tocopherol Reduces Hepatotoxicity Associated with Arsenic Trioxide Chemotherapy by Modulating Nrf2 and Bcl2 Transcription Factors in Chang liver Cells.
    Vineetha RC; Archana V; Binu P; Arathi P; Nair RH
    Nutr Cancer; 2018; 70(4):684-696. PubMed ID: 29697268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Biol Trace Elem Res; 2015 Feb; 163(1-2):112-23. PubMed ID: 25431299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
    Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Nrf2 Signaling Pathway Involving KLF9 Plays a Critical Role in Allicin Resisting Against Arsenic Trioxide-Induced Hepatotoxicity in Rats.
    Yang D; Lv Z; Zhang H; Liu B; Jiang H; Tan X; Lu J; Baiyun R; Zhang Z
    Biol Trace Elem Res; 2017 Mar; 176(1):192-200. PubMed ID: 27561292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
    Chen Z; Chen GQ; Shen ZX; Chen SJ; Wang ZY
    Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
    Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
    Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
    Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
    Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different administration patterns of docosahexaenoic acid in combating cytotoxic manifestations due to arsenic trioxide (acute promyelocytic leukemia drug) induced redox imbalance in hepatocytes.
    Abhilash S; Siviyasankar R; Binu P; Arathi P; Harikumaran Nair R
    Prostaglandins Other Lipid Mediat; 2018 May; 136():64-75. PubMed ID: 29751151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia drug - arsenic trioxide in the presence of eugenol shows differential action on leukemia cells (HL-60) and cardiomyocytes (H9c2) - inference from NMR study.
    Binu P; Soman R; Zakhariah Hisham O; Narayanan SP; Nair RH
    Toxicol Mech Methods; 2021 Jul; 31(6):457-466. PubMed ID: 33879037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic Trioxide Induces Apoptosis of HL-60 Cells via Activation of Intrinsic Caspase Protease with Mitochondrial Dysfunction.
    Jung BH; Park C; Kim HR; Park MR
    Cancer Res Treat; 2002 Aug; 34(4):308-15. PubMed ID: 26680881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
    Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
    J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
    Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
    Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
    Diaz Z; Laurenzana A; Mann KK; Bismar TA; Schipper HM; Miller WH
    Leukemia; 2007 Oct; 21(10):2117-27. PubMed ID: 17690699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide and ascorbic acid: synergy with potential implications for the treatment of acute myeloid leukaemia?
    Bachleitner-Hofmann T; Gisslinger B; Grumbeck E; Gisslinger H
    Br J Haematol; 2001 Mar; 112(3):783-6. PubMed ID: 11260084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells].
    Cai X; Chen G; Jia P
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):452-5. PubMed ID: 11715442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.